Question 1

What is the catalog number for Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208?

Accepted Answer

The catalog number for Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208 is UBD208a.

Question 2

What sizes are available for Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208?

Accepted Answer

Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208 is available in the following size(s): 64 Cases / 192 Cores.

Question 3

Is Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208 in stock?

Accepted Answer

Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208 used for?

Accepted Answer

Multiple bladder carcinoma with bladder tissue microarray, containing 38 cases of urothelial carcinoma, 6 squamous cell carcinoma, 7 adenocarcinoma, 4 metastatic urothelial carcinoma, 9 bladder tissue, triplicated cores per case

Question 5

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 6

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 7

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208

Product Specifications

Cases

Cores

Column

Frequently Asked Questions

Explore Other Products

EGFRvIII (Epidermal Growth Factor Receptor, Variant III) (GFR/2600R), CF568 conjugate, 0.1mg/mL

Anti-Laminin/Lamc1/Lamc2/Lamc3 Antibody Picoband® (Biotine Conjugate)

CD68 (KP1), CF647 conjugate, 0.1mg/mL

Anti-MRPS18B Antibody Picoband®, Dylight550 Conjugate

Calretinin / Calbindin 2 (Mesothelioma Marker) (CALB2/2603), Biotin conjugate, 0.1mg/mL

SDHB (Succinate Dehydrogenase B) (Pheochromocytoma Marker) (SDHB/2382), CF640R conjugate, 0.1mg/mL